142 related articles for article (PubMed ID: 3892637)
21. Evidence for a disease specific antigen in circulating immune complexes in ankylosing spondylitis.
Bruneau C; Bonin H
Clin Exp Immunol; 1983 Sep; 53(3):529-35. PubMed ID: 6616954
[TBL] [Abstract][Full Text] [Related]
22. Quantification of the C3 breakdown product C3d by rocket immunoelectrophoresis.
Ramentol-Massana M; Grau G; Beaumariage ML; Salmon J
Int Arch Allergy Appl Immunol; 1982; 68(3):219-21. PubMed ID: 7085116
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of six tests for circulating IgG complexes with special reference to IgM rheumatoid factors: analysis of systemic lupus erythematosus and rheumatoid arthritis series.
Wager O; Lindström P; Räsänen JA; Kekomäki R; Ziola B; Salmi A; Isomäki H; Skrifvars B; Penttinen K
Clin Exp Immunol; 1981 Oct; 46(1):149-60. PubMed ID: 7337967
[TBL] [Abstract][Full Text] [Related]
24. C3-containing serum immune complexes in patients with systemic lupus erythematosus: correlation to disease activity and comparison with other rheumatic diseases.
Huber C; Rüger A; Herrmann M; Krapf F; Kalden JR
Rheumatol Int; 1989; 9(2):59-64. PubMed ID: 2814209
[TBL] [Abstract][Full Text] [Related]
25. Quantitation and antigenic characterization of bound C3 of circulating immune complexes in systemic lupus erythematosus, rheumatoid arthritis, and primary biliary cirrhosis.
Nilsson B; Bjelle A; Lööf L; Nilsson UR
J Clin Immunol; 1987 Sep; 7(5):420-6. PubMed ID: 2443529
[TBL] [Abstract][Full Text] [Related]
26. Erythrocyte CR1 (C3b/C4b receptor) levels and disease activity in patients with SLE.
Thomsen BS; Nielsen H; Andersen V
Scand J Rheumatol; 1987; 16(5):339-46. PubMed ID: 2961056
[TBL] [Abstract][Full Text] [Related]
27. A new method for the detection of circulating immune complexes by immunoelectrophoretic analysis. II. Studies on human pathological and normal sera.
Swierczyńska Z; Woźniczko-Orłowska G; Rdułtowska H
Reumatologia; 1979; 17(3):279-84. PubMed ID: 515571
[No Abstract] [Full Text] [Related]
28. An enzyme-linked immunoassay for detection of IgG- and C3-containing circulating immune complexes: comparison with a radioimmunoassay and quantitation in patients with rheumatic diseases.
Panush RS; Somberg LB; Katz P; Longley S
Diagn Immunol; 1983; 1(4):288-94. PubMed ID: 6388973
[TBL] [Abstract][Full Text] [Related]
29. [Serum complement levels in patients with rheumatoid arthritis and vasculitis].
Tomooka K
Fukuoka Igaku Zasshi; 1989 Oct; 80(10):456-66. PubMed ID: 2613159
[TBL] [Abstract][Full Text] [Related]
30. Direct quantitation of activated C3 in human plasma with monoclonal anti-iC3b-C3d-neoantigen.
Kanayama Y; Kurata Y; McMillan R; Tamerius JD; Negoro N; Curd JG
J Immunol Methods; 1986 Apr; 88(1):33-6. PubMed ID: 2420896
[TBL] [Abstract][Full Text] [Related]
31. Determination of complement breakdown fragments C3d and its subfragments in health and disease.
Tamotsu M; Arai K; Fujita S; Hosotsubo K; Hayashi C; Miyai K; Miyano A; Kawanaka K; Takenaka M; Shimizu A
Diagn Immunol; 1984; 2(2):116-21. PubMed ID: 6333963
[TBL] [Abstract][Full Text] [Related]
32. Plasma C3d/C3 quotient as a parameter for in vivo complement activation.
Nürnberger W; Bhakdi S
J Immunol Methods; 1984 Nov; 74(1):87-91. PubMed ID: 6334115
[TBL] [Abstract][Full Text] [Related]
33. Complement C3c and C3d in plasma and synovial fluid in rheumatoid arthritis.
Berkowicz A; Kappelgaard E; Petersen J; Nielsen H; Ingemann-Hansen T; Halkjaer-Kristensen J; Sørensen H
Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):397-402. PubMed ID: 6608857
[TBL] [Abstract][Full Text] [Related]
34. [Functional analysis of immune complex-rich serum fractions in autoimmune diseases by in vitro C3 activation of fresh blood].
Böhm U; Merétey K; Falus A; Bozsóky S
Z Rheumatol; 1981; 40(3):126-30. PubMed ID: 6456623
[TBL] [Abstract][Full Text] [Related]
35. Evidence for the presence of circulating immune complexes in serum and C3b and C3d on red cells of kala-azar patients.
Kharazmi A; Rezai HR; Fani M; Behforouz NC
Trans R Soc Trop Med Hyg; 1982; 76(6):793-6. PubMed ID: 6761907
[TBL] [Abstract][Full Text] [Related]
36. Correlation of disease activity with circulating immune complexes (C1qbA) and complement breakdown products (C3D) in patients with systemic lupus erythematosus. A prospective study.
Swaak AJ; Groenwold J; Hannema A; Hack CE
Rheumatol Int; 1985; 5(5):215-20. PubMed ID: 3877968
[TBL] [Abstract][Full Text] [Related]
37. Circulating immune complexes in patients with ankylosing spondylitis.
Panayi GS; Slaney J; Williams BD
Ann Rheum Dis; 1980 Oct; 39(5):445-8. PubMed ID: 7436575
[TBL] [Abstract][Full Text] [Related]
38. Immunonephelometric quantitation of complement split product (C3d) plasma levels in rheumatic disease.
von Essen R; Isomäki H
Scand J Rheumatol; 1985; 14(4):421-6. PubMed ID: 3878584
[TBL] [Abstract][Full Text] [Related]
39. Determination of the half-life of C3 in patients and its relation to the presence of C3-breakdown products and/or circulating immune complexes.
Swaak AJ; Hannema A; Vogelaar C; Boom FA; van Es L; van Aalst R; Statius van Eps LW
Rheumatol Int; 1982; 2(4):161-6. PubMed ID: 6984977
[TBL] [Abstract][Full Text] [Related]
40. Immunological studies in seronegative spondyloarthropathies.
Prakash S; Bansal R; Rajagopalan P; Malaviya AN
Br J Rheumatol; 1983 Aug; 22(3):146-50. PubMed ID: 6871581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
